Investigation Overview
February 11, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) shares was initiated over potential securities laws violations by Oramed Pharmaceuticals and certain of its directors and officers in connection certain financial statements. The investigation by a law firm focuses on possible claims on behalf of purchas...
You must register (for free) or login to view the entire investigation.